Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients - Université de Rennes Access content directly
Journal Articles European Heart Journal - Cardiovascular Imaging Year : 2017

Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients

Pasquale Perrone-Filardi
  • Function : Correspondent author
Antonio Coca
  • Function : Author
Maurizio Galderisi
  • Function : Author
Giovanni de Simone
  • Function : Author
Thomas Kahan
  • Function : Author
Giuseppe Mancia
  • Function : Author
Josep Redon
  • Function : Author
Roland Schmieder
Bryan Williams
  • Function : Author

Abstract

Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.

Dates and versions

hal-01613517 , version 1 (09-10-2017)

Identifiers

Cite

Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, Stefania Paolillo, Francisco Alpendurada, et al.. Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients. European Heart Journal - Cardiovascular Imaging, 2017, 18 (9), pp.945-960. ⟨10.1093/ehjci/jex094⟩. ⟨hal-01613517⟩
73 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More